Back
27 Jun 2025
Tianjin Da Ren Tang Completes RMB1.62 Billion Disposal of Final 12% Stake in Tianjin TSKF to Haleon
Summary:
-
Tianjin Pharmaceutical Da Ren Tang Group has completed the sale of its remaining 12% equity stake in Tianjin TSKF Pharmaceutical Co., Ltd.
-
The stake was sold to Haleon China Co., Ltd. and Haleon CH SARL for a total consideration of RMB1.62 billion.
-
Industrial and commercial registration formalities for the disposal have been completed.
-
Following this transaction, the company no longer holds any equity in Tianjin TSKF.
-
The disposal was approved by shareholders at the EGM on 9 June 2025.